Intensified antineoplastic effect by combining an HDAC‐inhibitor, an mTOR‐inhibitor and low dosed interferon alpha in prostate cancer cells
Publisher： John Wiley & Sons Inc
E-ISSN： 1582-4934|19|8|1795-1804
ISSN： 1582-1838
Source： Journal of Cellular and Molecular Medicine, Vol.19, Iss.8, 2015-08, pp. : 1795-1804
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
